T167-0107 Screening compound: 2-(4-fluorophenoxy)-N~1~-[1-(6-oxo-1,6-dihydro-4-pyridazinyl)-4-piperidyl]acetamide

T167-0107 Screening compound: 2-(4-fluorophenoxy)-N~1~-[1-(6-oxo-1,6-dihydro-4-pyridazinyl)-4-piperidyl]acetamide
T167-0107 Screening compound: 2-(4-fluorophenoxy)-N~1~-[1-(6-oxo-1,6-dihydro-4-pyridazinyl)-4-piperidyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T167-0107
2-(4-fluorophenoxy)-N~1~-[1-(6-oxo-1,6-dihydro-4-pyridazinyl)-4-piperidyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T167-0107

Molecular Formula

C17H19FN4O3 (C17 H19 FN4 O3)

Compound Name

2-(4-fluorophenoxy)-N~1~-[1-(6-oxo-1,6-dihydro-4-pyridazinyl)-4-piperidyl]acetamide

IUPAC name

n/a

SMILES

O=C(COc(cc1)ccc1F)NC(CC1)CCN1C(C=NN1)=CC1=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

346.36

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.596

Distribution Coefficient, logD

1.589

Water Solubility, LogSw

-2.02

Polar Surface Area

73.401

Acid Dissociation Constant (pKa)

12.52

Base Dissociation Constant (pKb)

4.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

T167-0107 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

Bromodomain Modulators Library (5801 compounds)

GPCR Targeted Library (31838 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Eye
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Others
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T167-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T167-0107?
Check Price and Availability of T167-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T167-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T167-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T167-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T167-0107 available by request